Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-EVs in Premature Ovarian Failure
NCT06202547Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Feb 2023
- Primary completion
- Oct 2024
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow mesenchymal stromal cells-derived extracellular vesicles in primary ovarian insufficiency (POI), sponsored by Royan Institute. Started Feb 2023; status: completed.
02
Drugs
bone marrow mesenchymal stromal cells-derived extracellular vesicles
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT06202547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06202547.